Thanks plavac, Yes, I would think the off-label

Thanks plavac,

Yes, I would think the off-label use will be important down-the-road. There are two main reasons for this:

1) It has proven to be safe. Or, shall I say VERY safe ??
2) It is proving to have myriad applications (exactly the "door" for off-label use).

I have been reading about this usage (after you mentioned it in a previous posting) and the more I learn the more I think that there is a humongous potential for revenue coming this way. I hope the licensing deal includes prevision(s) for this market.

Quote:

---

This law includes off-label uses if the treatment has been tested in careful research studies and written up in well-respected drug reference books or medical journals. In 2008, Medicare rules were changed to cover more off-label uses of cancer treatment drugs.

---

Quote:

---

If your doctor is thinking about off-label drug use, you and your doctor should carefully check your health plan’s coverage. If you are denied coverage, it might help if the doctor sends the insurer copies of peer-reviewed journal articles or other respected sources that support the off-label use."

---

I would think Leronlimab would comply with the above. Wouldn't it?